| Anticipating the interaction between technology and morality: A scenario study of experimenting with humans in bionanotechnology M Boenink, T Swierstra, D Stemerding Studies in ethics, law, and technology 4 (2), 2010 | 224 | 2010 |
| Exploring techno-moral change: the case of the obesitypill T Swierstra, D Stemerding, M Boenink Evaluating New Technologies: Methodological Problems for the Ethical …, 2009 | 192 | 2009 |
| Beyond bench and bedside: disentangling the concept of translational research AL Van der Laan, M Boenink Health care analysis 23, 32-49, 2015 | 157 | 2015 |
| Assessing expectations: Towards a toolbox for an ethics of emerging technologies F Lucivero, T Swierstra, M Boenink NanoEthics 5, 129-141, 2011 | 120 | 2011 |
| Values in responsible research and innovation: from entities to practices M Boenink, O Kudina Journal of Responsible Innovation 7 (3), 450-470, 2020 | 115 | 2020 |
| Molecular medicine and concepts of disease: the ethical value of a conceptual analysis of emerging biomedical technologies M Boenink Medicine, health care and philosophy 13, 11-23, 2010 | 84 | 2010 |
| The benefits of patient involvement for translational research L Van der Scheer, E Garcia, AL van der Laan, S van der Burg, M Boenink Health Care Analysis 25, 225-241, 2017 | 63 | 2017 |
| Taking care of the symbolic order. How converging technologies challenge our concepts T Swierstra, R van Est, M Boenink Nanoethics 3, 269-280, 2009 | 50 | 2009 |
| Exploring the interaction between technology and morality in the field of genetic susceptibility testing: A scenario study D Stemerding, T Swierstra, M Boenink Futures 42 (10), 1133-1145, 2010 | 39 | 2010 |
| Can we learn from hidden mistakes? Self-fulfilling prophecy and responsible neuroprognostic innovation M Mertens, OC King, MJAM Van Putten, M Boenink Journal of Medical Ethics 48 (11), 922-928, 2022 | 38 | 2022 |
| Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine E Fisher, M Boenink, S Van Der Burg, N Woodbury Expert Review of Molecular Diagnostics 12 (8), 857-870, 2012 | 37 | 2012 |
| Converging technologies, shifting boundaries T Swierstra, M Boenink, B Walhout, R Van Est NanoEthics 3, 213-216, 2009 | 35 | 2009 |
| Tensions and opportunities in convergence: Shifting concepts of disease in emerging molecular medicine M Boenink Nanoethics 3, 243-255, 2009 | 31 | 2009 |
| The multiple practices of doing ‘ethics in the laboratory’: A mid-level perspective M Boenink Ethics on the laboratory floor, 57-78, 2013 | 24 | 2013 |
| Giving voice to patients: developing a discussion method to involve patients in translational research M Boenink, L van der Scheer, E Garcia, S van der Burg NanoEthics 12, 181-197, 2018 | 23 | 2018 |
| Emerging technologies for diagnosing Alzheimer’s Disease: Innovating with care M Boenink, H Van Lente, E Moors Emerging Technologies for Diagnosing Alzheimer's Disease: Innovating with …, 2016 | 23 | 2016 |
| Genetic diagnostics for hereditary breast cancer: displacement of uncertainty and responsibility M Boenink Genetics from Laboratory to Society: Societal Learning as an Alternative to …, 2008 | 21 | 2008 |
| Leven als bouwpakket: ethisch verkennen van de nieuwe technologische golf T Swierstra, M Boenink, B Walhout, R van Est Rathenau Instituut, 2009 | 19 | 2009 |
| Biomarkers for dementia: too soon for routine clinical use JD Isaacs, M Boenink The Lancet Neurology 19 (11), 884-885, 2020 | 17 | 2020 |
| Gatekeeping and trailblazing: The role of biomarkers in novel guidelines for diagnosing Alzheimer’s disease M Boenink Biosocieties 13 (1), 213-231, 2018 | 17 | 2018 |
